Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Maternal-fetal medicine Stories

2012-08-14 06:28:03

PRINCETON, N.J., Aug. 14, 2012 /PRNewswire/ -- PeriGen, Inc., and The George Washington University, the data coordinating center of the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Maternal-Fetal Medicine Units Network, have entered into an agreement to utilize PeriGen's PeriCALM® Patterns(TM) software in connection with a research project entitled: Computerized Interpretation of Intrapartum FHR and Prediction of Neonatal Outcomes. The primary...

2012-05-01 02:32:30

SAN JOSE, Calif., May 1, 2012 /PRNewswire/ -- Ariosa Diagnostics, Inc., a molecular diagnostics company, is pleased to announce that Thomas J. Musci, M.D. will lead the clinical development and medical affairs of the company. (Logo: http://photos.prnewswire.com/prnh/20120326/NY75864LOGO) Dr. Musci is board-certified in Maternal-Fetal Medicine and Genetics and has had an extensive career in academics, private practice and industry. Recognized as a leader in clinical research on prenatal...

2012-02-14 09:21:00

CHATTANOOGA, Tenn., Feb. 14, 2012 /PRNewswire/ -- Glenveigh Medical announced today that the U.S. Food and Drug Administration (FDA) has granted its request for orphan drug designation for a potential new therapy to treat severe preeclampsia and eclampsia. The compound, digoxin immune fab (ovine), is an existing biologic approved for use in cases of digoxin toxicity. Glenveigh, a nationally renowned life science company, has extensive clinical and in vitro evidence to support...

2012-02-13 11:13:05

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in the first trimester do not predict the subsequent development of preeclampsia. "I wanted to identify if elevated levels of cell-free fetal DNA in maternal blood early in pregnancy could identify women at risk for the subsequent development of preeclampsia. I found that...

2012-02-13 11:11:53

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in Dallas, Texas, researchers will report findings that show that short therapy with the anti-diabetic medication Pioglitazone can prevent the long term effects of maternal obesity on offspring. This study, Pioglitazone Therapy in Offspring Exposed to Maternal Obesity, is the first step in the long term goal of preventing metabolic syndrome and obesity in children secondary...

2012-02-10 14:54:18

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in Dallas, Texas, researchers will report findings that indicate that the risk of obstetric intervention is lower for women who deliver or intend to deliver outside of hospitals, but there are some higher risks for newborns intended for home births compared to hospital births. The study, Neonatal Outcomes Associated with Intended Place of Birth: Birth Centers and Home Birth...

2012-02-10 14:32:58

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in Dallas, Texas, researchers will report findings that indicate that massively parallel sequencing can be used to diagnose fetal aneuploidies, including Down syndrome, Edwards syndrome, Patau syndrome and Turner syndrome. Because of the importance of the clinical data, the abstract, entitled Genome Wide Fetal Aneuploidy Detection by Sequencing of Maternal Plasma DNA:...

2012-02-10 14:29:00

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in Dallas, Texas, researchers will report findings that show that in women with acute postpartum anemia, due to excessive blood loss during delivery, red blood cell transfusion led to a statistically significant decrease in physical fatigue. While excessive blood loss during delivery caused severe physical fatigue, the effect of red blood cell transfusion on this fatigue was...

2012-02-10 14:22:43

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in Dallas, Texas, researchers will report findings that indicate that preterm birth interventions should be tailored for underlying risk factors and pathways. "Pathophysiologic pathways leading to preterm labor and delivery are not the same in each and every subject and vary based on an individual's risk exposure. This can include her race, type of infectious agent or...

2012-02-09 12:25:26

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting , in Dallas, Texas, researchers will report findings that suggest that induction of labor in patients who suffer a rupture of membranes between the 34th and 37th week of gestation (before the onset of labor) does not reduce the risk of infection or respiratory problems in the newborn. "Our research indicates that in patients who underwent close monitoring, known as expectant...